134 related articles for article (PubMed ID: 15103688)
21. Household contact study of Bordetella pertussis infections.
Deen JL; Mink CA; Cherry JD; Christenson PD; Pineda EF; Lewis K; Blumberg DA; Ross LA
Clin Infect Dis; 1995 Nov; 21(5):1211-9. PubMed ID: 8589145
[TBL] [Abstract][Full Text] [Related]
22. Serological correlates in whooping cough.
Granström M; Granström G
Vaccine; 1993; 11(4):445-8. PubMed ID: 8470429
[TBL] [Abstract][Full Text] [Related]
23. Effect of erythromycin treatment on antibody responses in pertussis.
Granström G; Granström M
Scand J Infect Dis; 1994; 26(4):453-7. PubMed ID: 7984978
[TBL] [Abstract][Full Text] [Related]
24. Immune responses to Bordetella pertussis infection and vaccination.
Tomoda T; Ogura H; Kurashige T
J Infect Dis; 1991 Mar; 163(3):559-63. PubMed ID: 1995729
[TBL] [Abstract][Full Text] [Related]
25. Protective role of immunoglobulin G antibodies to filamentous hemagglutinin and pertactin of Bordetella pertussis in Bordetella parapertussis infection.
He Q; Edelman K; Arvilommi H; Mertsola J
Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):793-8. PubMed ID: 8950556
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence of pertussis in China: need to improve vaccination strategies.
Xu Y; Wang L; Xu J; Wang X; Wei C; Luo P; Ma X; Hou Q; Wang J
Hum Vaccin Immunother; 2014; 10(1):192-8. PubMed ID: 24018405
[TBL] [Abstract][Full Text] [Related]
27. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children.
Hendrikx LH; Schure RM; Oztürk K; de Rond LG; de Greeff SC; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Sep; 29(40):6874-80. PubMed ID: 21803088
[TBL] [Abstract][Full Text] [Related]
28. Serum IgG antibody response to pertussis toxin in persons for whom pertussis vaccination failed depends upon the number of antigens in the vaccine.
Cherry JD
Clin Infect Dis; 1999 Mar; 28(3):560-1. PubMed ID: 10194078
[No Abstract] [Full Text] [Related]
29. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. I. Antibody level for B pertussis antigens in children without respiratory tract infection symptoms].
Chodorowska M
Med Dosw Mikrobiol; 1999; 51(3-4):259-68. PubMed ID: 10803255
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
[TBL] [Abstract][Full Text] [Related]
31. Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana.
Afari EA; Kamiya Y; Nkrumah FK; Dunyo SK; Akpedonu P; Kamiya H; Fukai F
Ann Trop Paediatr; 1996 Mar; 16(1):39-48. PubMed ID: 8787364
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren.
He Q; Viljanen MK; Olander RM; Bogaerts H; De Grave D; Ruuskanen O; Mertsola J
J Infect Dis; 1994 Sep; 170(3):705-8. PubMed ID: 8077734
[TBL] [Abstract][Full Text] [Related]
33. Western blot analysis of antibody responses of young infants to pertussis infection.
Guiso N; Grimprel E; Anjak I; Bégué P
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):596-600. PubMed ID: 8223658
[TBL] [Abstract][Full Text] [Related]
34. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
Cherry JD; Gornbein J; Heininger U; Stehr K
Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
[TBL] [Abstract][Full Text] [Related]
35. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
Thomas MG; Ashworth LA; Miller E; Lambert HP
J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
[TBL] [Abstract][Full Text] [Related]
36. Determination of pertactin IgG antibodies for the diagnosis of pertussis.
Trollfors B; Lagergård T; Gunnarsson E; Taranger J
Clin Microbiol Infect; 2003 Jul; 9(7):585-9. PubMed ID: 12925096
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
[TBL] [Abstract][Full Text] [Related]
38. Seroepidemiology of pertussis in senior adults.
Neuzil KM; Edwards KM; Reed GW
Clin Infect Dis; 2001 Mar; 32(5):847-8. PubMed ID: 11229862
[No Abstract] [Full Text] [Related]
39. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.
Grimprel E; Bégué P; Anjak I; Njamkepo E; François P; Guiso N
Clin Diagn Lab Immunol; 1996 Jan; 3(1):93-7. PubMed ID: 8770511
[TBL] [Abstract][Full Text] [Related]
40. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
